Drug Delivery Landscape in Cancer Research
- 1st Edition - June 9, 2025
- Latest edition
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
Drug Delivery Landscape in Cancer Research examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospe… Read more
Drug Delivery Landscape in Cancer Research examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of cancer drug delivery technology, the book examines clinical translation-related knowledge and the development of different organ related cancers. In 22 chapters, it describes current and new drug delivery systems in twenty different cancers and gives insights into drug delivery strategies and tumor microenvironment management in oral and ocular cancers. This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and anyone who wants to broaden their knowledge.
- Contains current studies of the targeted use of drug delivery systems based on the microenvironmental properties of different cancer types
- Provides essential information on the most recent drug delivery systems available for different cancer types
- Explains current technology and its applications to drug delivery in cancer
- Contains contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers
Researchers working across the biosciences in fields of oncology, pharmacology
1. Liver cancer: current and new drug delivery systems
2. Pancreatic cancer: current and new drug delivery systems
3. Heart cancer: current and new drug delivery systems
4. Bone cancer: current and new drug delivery systems
5. Spleen cancer: current and new drug delivery systems
6. ENT cancer: current and new drug delivery systems
7. Brain/CNS cancer: current and new drug delivery systems
8. Skin cancer: current and new drug delivery systems
9. Lung cancer: current and new drug delivery systems
10. Thorax cancer: current and new drug delivery systems
11. Thyroid cancer: current and new drug delivery systems
12. Kidney-adrenal: current and new drug delivery systems
13. Urinary track: current and new drug delivery systems
14. Breast: current and new drug delivery systems
15. Colorectal: current and new drug delivery systems
16. Blood cancer: current and new drug delivery systems
17. Prostate cancer: current and new drug delivery systems
18. Ovarian cancer: current and new drug delivery systems
19. Stomach and intestinal cancer: current and new drug delivery systems
20. Plural and peritoneum Cancer: current and new drug delivery systems
21. Drug Delivery Strategies and trends in management of tumour microenvironment of oral cancer
22. Drug Delivery Strategies and trends in ocular cancer
2. Pancreatic cancer: current and new drug delivery systems
3. Heart cancer: current and new drug delivery systems
4. Bone cancer: current and new drug delivery systems
5. Spleen cancer: current and new drug delivery systems
6. ENT cancer: current and new drug delivery systems
7. Brain/CNS cancer: current and new drug delivery systems
8. Skin cancer: current and new drug delivery systems
9. Lung cancer: current and new drug delivery systems
10. Thorax cancer: current and new drug delivery systems
11. Thyroid cancer: current and new drug delivery systems
12. Kidney-adrenal: current and new drug delivery systems
13. Urinary track: current and new drug delivery systems
14. Breast: current and new drug delivery systems
15. Colorectal: current and new drug delivery systems
16. Blood cancer: current and new drug delivery systems
17. Prostate cancer: current and new drug delivery systems
18. Ovarian cancer: current and new drug delivery systems
19. Stomach and intestinal cancer: current and new drug delivery systems
20. Plural and peritoneum Cancer: current and new drug delivery systems
21. Drug Delivery Strategies and trends in management of tumour microenvironment of oral cancer
22. Drug Delivery Strategies and trends in ocular cancer
- Edition: 1
- Latest edition
- Published: June 9, 2025
- Language: English
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
Affiliations and expertise
Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, GermanyYP
Yashwant Pathak
Yashwant Pathak is a Professor and Associate Dean for faculty affairs at the Taneja College of Pharmacy at the University of South Florida, Tampa, USA. Prof. Pathak is also an Adjunct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia. His area of research is in health care education, nanotechnology, drug delivery systems, and nutraceuticals.
Affiliations and expertise
Professor and Associate Dean, Faculty Affairs, College of Pharmacy, University of South Florida, Tampa, USARead Drug Delivery Landscape in Cancer Research on ScienceDirect